SpinaFX Medical, a clinical-stage medical device company specializing in minimally invasive, image-guided therapies for ...
The planned trial is expected to include 300 participants across two treatment arms.
SpinaFX Medical earned the FDA’s investigational device exemption for Triojection, an intradiscal ozone/oxygen injection, according to a June 9 news release. Triojection will be evaluated in a U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results